Intravenous (IV) iron drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market includes the growing prevalence of chronic kidney disease (CKD), inflammatory bowel disease (IBD), and cancer around the globe, which has led to an increase in the need for intravenous iron drugs for the treatment of subsequent iron deficiency anemia (IDA). In addition, approval and launch of novel formulations and strategic initiatives undertaken by key players to improve access to intravenous iron drugs are further expected to support market growth. Increasing prevalence of target diseases, such as rheumatoid arthritis, autoimmune diseases, kidney conditions, cancer, liver disorders, thyroid diseases, and inflammatory bowel diseases, is another factor that accelerates the growth of the global intravenous (IV) iron drugs market. Some of the most common forms of anemia include iron and vitamin deficiency, a plastic, hemolytic, and sickle cell. Some of the common causes of anemia include iron, vitamin A and B12, and folate deficiencies. Infectious diseases such as tuberculosis, parasitic infections, malaria, and HIV are major causes of anemia across the globe.
Furthermore, other advantages of intravenous iron drugs include the preservation of heart health and the ability to be used by dialysis patients, especially those undergoing hemodialysis. These adverse effects are, hence, anticipated to facilitate the switch to intravenous iron drugs, increasing the uptake of the same during the forecast period. The global intravenous iron drugs market is highly competitive owing to the presence of several global players. Market participants such as Daiichi Sankyo Company, Ltd. and Vifor Pharma Management Ltd. accounted for the majority of market revenue share in 2020. They adopt different growth strategies such as new product development and expansion of geographical reach, to capture large share in the market. For instance, in September 2020, the company announced the establishment of its wholly-owned subsidiary Daiichi Sankyo Vietnam Co., Ltd. This initiative was undertaken in order to enhance the company’s business in Asia.
To Request a Sample of our Report on Intravenous (IV) Iron Drugs Market: https://www.omrglobal.com/request-sample/intravenous-iv-iron-drugs-market
Market Coverage
- The market number available for – 2023-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Product Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Vifor Pharma Management Ltd., Daiichi Sankyo Company, Ltd., and Sanofi S.A., among others.
Intravenous (IV) Iron Drugs Market Report by Segment
By Product Type
- Iron Dextran
- Ferric Carboxymaltose
- Iron Sucrose
- Ferric Gluconate
By Application
- Cancer
- Nephrology
- Gastroenterology and Obstetrics
- Gynecology
- Cardiology
- Others
A full Report of Intravenous (IV) Iron Drugs Market is Available @ https://www.omrglobal.com/industry-reports/intravenous-iv-iron-drugs-market
Intravenous (IV) Iron Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/intravenous-iv-iron-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404